2018
DOI: 10.1016/j.ejmech.2018.02.055
|View full text |Cite
|
Sign up to set email alerts
|

A novel synthetic peptide inspired on Lys49 phospholipase A 2 from Crotalus oreganus abyssus snake venom active against multidrug-resistant clinical isolates

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
23
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 31 publications
(23 citation statements)
references
References 42 publications
0
23
0
Order By: Relevance
“…Peptide pC‐CoaTxII showed greater activity against Gram‐negative bacteria, although its effects against Gram‐positive bacteria were significant. Experimental results show pC‐CoaTx‐II to be more active against both ATCC and clinical drug‐resistant isolates, as compared to the parent protein (Almeida et al, ).…”
Section: Svpla2s‐inspired Antimicrobial Peptidesmentioning
confidence: 98%
See 4 more Smart Citations
“…Peptide pC‐CoaTxII showed greater activity against Gram‐negative bacteria, although its effects against Gram‐positive bacteria were significant. Experimental results show pC‐CoaTx‐II to be more active against both ATCC and clinical drug‐resistant isolates, as compared to the parent protein (Almeida et al, ).…”
Section: Svpla2s‐inspired Antimicrobial Peptidesmentioning
confidence: 98%
“…Though some studies have validated the antibacterial potential of C‐terminal region of Asp49 PLA 2 s (Costa et al, ), multiple studies have been carried out on Lys49 PLA 2 s, due to the independence of catalytic activity suggesting the presence of noncatalytic molecular regions capable of exerting different bioactivities. In this connection, Lomonte, Moreno, Tarkowski, Hanson, and Maccarana () demonstrated for the first time that biomimetic peptides replicate the effects of their parent svPLA 2 s. Since this pioneering study, many synthetic peptides based on the same molecular regions were evaluated for a better understanding of the mechanisms of myotoxic, antibacterial, antiviral, and antitumoral actions of Lys49 svPLA 2 s (Almeida et al, ; Gebrim et al, ; Lomonte et al, ). Therefore, these catalytically inactive toxins are taken as valuable templates for creation and innovation in antibiotherapy, building on smaller peptide segments with antibacterial potential (Figure ).…”
Section: Svpla2s‐inspired Antimicrobial Peptidesmentioning
confidence: 99%
See 3 more Smart Citations